223 related articles for article (PubMed ID: 32958768)
1. Elucidation of the aberrant 3' splice site selection by cancer-associated mutations on the U2AF1.
Yoshida H; Park SY; Sakashita G; Nariai Y; Kuwasako K; Muto Y; Urano T; Obayashi E
Nat Commun; 2020 Sep; 11(1):4744. PubMed ID: 32958768
[TBL] [Abstract][Full Text] [Related]
2. A splice site-sensing conformational switch in U2AF2 is modulated by U2AF1 and its recurrent myelodysplasia-associated mutation.
Warnasooriya C; Feeney CF; Laird KM; Ermolenko DN; Kielkopf CL
Nucleic Acids Res; 2020 Jun; 48(10):5695-5709. PubMed ID: 32343311
[TBL] [Abstract][Full Text] [Related]
3. Global analysis of binding sites of U2AF1 and ZRSR2 reveals RNA elements required for mutually exclusive splicing by the U2- and U12-type spliceosome.
Kwon YS; Jin SW; Song H
Nucleic Acids Res; 2024 Feb; 52(3):1420-1434. PubMed ID: 38088204
[TBL] [Abstract][Full Text] [Related]
4. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.
Biancon G; Joshi P; Zimmer JT; Hunck T; Gao Y; Lessard MD; Courchaine E; Barentine AES; Machyna M; Botti V; Qin A; Gbyli R; Patel A; Song Y; Kiefer L; Viero G; Neuenkirchen N; Lin H; Bewersdorf J; Simon MD; Neugebauer KM; Tebaldi T; Halene S
Mol Cell; 2022 Mar; 82(6):1107-1122.e7. PubMed ID: 35303483
[TBL] [Abstract][Full Text] [Related]
5. mTOR-regulated U2af1 tandem exon splicing specifies transcriptome features for translational control.
Chang JW; Yeh HS; Park M; Erber L; Sun J; Cheng S; Bui AM; Fahmi NA; Nasti R; Kuang R; Chen Y; Zhang W; Yong J
Nucleic Acids Res; 2019 Nov; 47(19):10373-10387. PubMed ID: 31504847
[TBL] [Abstract][Full Text] [Related]
6. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.
Jenkins JL; Kielkopf CL
Trends Genet; 2017 May; 33(5):336-348. PubMed ID: 28372848
[TBL] [Abstract][Full Text] [Related]
7. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
[TBL] [Abstract][Full Text] [Related]
8. U2AF1 mutations alter splice site recognition in hematological malignancies.
Ilagan JO; Ramakrishnan A; Hayes B; Murphy ME; Zebari AS; Bradley P; Bradley RK
Genome Res; 2015 Jan; 25(1):14-26. PubMed ID: 25267526
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of U2AF1 reveals a shared repression mechanism for duplicated exons.
Kralovicova J; Vorechovsky I
Nucleic Acids Res; 2017 Jan; 45(1):417-434. PubMed ID: 27566151
[TBL] [Abstract][Full Text] [Related]
10. Splice site m
Mendel M; Delaney K; Pandey RR; Chen KM; Wenda JM; Vågbø CB; Steiner FA; Homolka D; Pillai RS
Cell; 2021 Jun; 184(12):3125-3142.e25. PubMed ID: 33930289
[TBL] [Abstract][Full Text] [Related]
11. The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.
Palangat M; Anastasakis DG; Fei DL; Lindblad KE; Bradley R; Hourigan CS; Hafner M; Larson DR
Genes Dev; 2019 May; 33(9-10):482-497. PubMed ID: 30842218
[TBL] [Abstract][Full Text] [Related]
12. Recognition of the 3' splice site RNA by the U2AF heterodimer involves a dynamic population shift.
Voith von Voithenberg L; Sánchez-Rico C; Kang HS; Madl T; Zanier K; Barth A; Warner LR; Sattler M; Lamb DC
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7169-E7175. PubMed ID: 27799531
[TBL] [Abstract][Full Text] [Related]
13. A novel 3' splice site recognition by the two zinc fingers in the U2AF small subunit.
Yoshida H; Park SY; Oda T; Akiyoshi T; Sato M; Shirouzu M; Tsuda K; Kuwasako K; Unzai S; Muto Y; Urano T; Obayashi E
Genes Dev; 2015 Aug; 29(15):1649-60. PubMed ID: 26215567
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Associated Mutations Mapped on High-Resolution Structures of the U2AF2 RNA Recognition Motifs.
Glasser E; Agrawal AA; Jenkins JL; Kielkopf CL
Biochemistry; 2017 Sep; 56(36):4757-4761. PubMed ID: 28850223
[TBL] [Abstract][Full Text] [Related]
15. Representative cancer-associated U2AF2 mutations alter RNA interactions and splicing.
Maji D; Glasser E; Henderson S; Galardi J; Pulvino MJ; Jenkins JL; Kielkopf CL
J Biol Chem; 2020 Dec; 295(50):17148-17157. PubMed ID: 33020180
[TBL] [Abstract][Full Text] [Related]
16. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
Graubert TA; Shen D; Ding L; Okeyo-Owuor T; Lunn CL; Shao J; Krysiak K; Harris CC; Koboldt DC; Larson DE; McLellan MD; Dooling DJ; Abbott RM; Fulton RS; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Grillot M; Baty J; Heath S; Frater JL; Nasim T; Link DC; Tomasson MH; Westervelt P; DiPersio JF; Mardis ER; Ley TJ; Wilson RK; Walter MJ
Nat Genet; 2011 Dec; 44(1):53-7. PubMed ID: 22158538
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes.
Martínez-Valiente C; Garcia-Ruiz C; Rosón B; Liquori A; González-Romero E; Fernández-González R; Gómez-Redondo I; Cervera J; Gutiérrez-Adán A; Sanjuan-Pla A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203454
[TBL] [Abstract][Full Text] [Related]
18. Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation.
Akef A; McGraw K; Cappell SD; Larson DR
PLoS Biol; 2020 Nov; 18(11):e3000920. PubMed ID: 33137094
[TBL] [Abstract][Full Text] [Related]
19. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
Morrison A; Chekaluk Y; Bacares R; Ladanyi M; Zhang L
PLoS One; 2015; 10(4):e0119224. PubMed ID: 25830670
[TBL] [Abstract][Full Text] [Related]
20. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
